The Radiation Oncology Residency Program was reestablished during the 1993-1994 school year at the Emory University School of Medicine. Positions are filled through the National Resident Matching Program. Applicants are accepted at the PGY-1 level and receive their first year of training with the Department of Medicine. The program consists of a one-year internship in internal medicine followed by a four-year residency in radiation oncology.
The program utilizes all of the resources of the Emory University System of Healthcare. This system includes the facilities and patient bases of Emory University Hospital, The Emory Clinic, Children's Healthcare of Atlanta, Grady Memorial Hospital, Emory University Hospital Midtown and the Veterans Affairs Medical Center.
For their clinical rotations in radiation oncology, residents are assigned to one of the facilities on a rotating basis. Most clinical rotations are three months in duration. The resident is expected to learn the presentation, evaluation, staging, radiation therapy techniques, relevant literature, and clinical management of each patient encountered on the rotation. Progressive and increasing responsibilities are delegated to residents commensurate with their knowledge and experience. Clinical research protocols are available through our affiliation with RTOG, GOG, ECOG, NSABP, POG and Brain Tumor Study Group. Residents also are encouraged to enroll patients on clinical protocols.
The requirements for successful completion of the residency program include preparation of at least one manuscript suitable for publication. Usually during the PGY-3 or -4 year, residents have 6 month of research in clinical radiation oncology, radiation biology, radiation physics, or some combination of these. Residents may elect rotations in other oncologic subspecialties including surgical oncology, medical oncology, pediatric medical oncology and pathology.
Presently there are 31 full-time faculty members in the Department of Radiation Oncology, comprising 18 radiation oncologists (MD or MD/Phd) in the Clinical Division, 6 physicists (PhD) in the Division of Medical Physics, and 7 biologists (PhD) in the Division of Cancer Biology.